Wu Y, Zhou T, Qian D, Liu X, Xu Y, Hong W, et al
While SURPASS-CVOT showed that tirzepatide was noninferior to dulaglutide, uncertainty remains regarding how tirzepatide compares to the broader GLP-1RA class and other GLP-1RA agents, and the extent to which it provides incremental benefit over placebo
Together in the cagrilintide semaglutide blend, these peptides create full appetite suppression that addresses hunger from multiple angles
Hims stands out for offering an all-in-one model thats predictable, convenient, and quick to start
It may also help reduce symptoms such as muscle cramps, fatigue, and headaches